BP’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,084
Closed -$934K 575
2021
Q2
$934K Sell
5,084
-2,054
-29% -$377K 0.04% 256
2021
Q1
$1.09M Sell
7,138
-2,216
-24% -$339K 0.04% 275
2020
Q4
$1.46M Sell
9,354
-10,946
-54% -$1.71M 0.04% 242
2020
Q3
$2.32M Sell
20,300
-1,700
-8% -$194K 0.06% 257
2020
Q2
$2.47M Hold
22,000
0.09% 238
2020
Q1
$1.98M Hold
22,000
0.08% 235
2019
Q4
$2.38M Buy
22,000
+500
+2% +$54K 0.08% 257
2019
Q3
$2.11M Sell
21,500
-500
-2% -$49K 0.08% 277
2019
Q2
$2.88M Hold
22,000
0.11% 217
2019
Q1
$2.97M Sell
22,000
-4,000
-15% -$541K 0.12% 207
2018
Q4
$2.53M Hold
26,000
0.11% 213
2018
Q3
$3.61M Hold
26,000
0.11% 208
2018
Q2
$3.23M Hold
26,000
0.1% 219
2018
Q1
$2.9M Hold
26,000
0.11% 231
2017
Q4
$3.11M Hold
26,000
0.11% 222
2017
Q3
$3.65M Hold
26,000
0.13% 205
2017
Q2
$3.16M Hold
26,000
0.12% 223
2017
Q1
$3.15M Buy
26,000
+19,000
+271% +$2.3M 0.12% 217
2016
Q4
$856K Hold
7,000
0.03% 415
2016
Q3
$858K Hold
7,000
0.03% 384
2016
Q2
$817K Hold
7,000
0.03% 337
2016
Q1
$975K Sell
7,000
-13,000
-65% -$1.81M 0.04% 306
2015
Q4
$3.82M Sell
20,000
-7,000
-26% -$1.34M 0.16% 178
2015
Q3
$4.22M Hold
27,000
0.19% 153
2015
Q2
$4.88M Sell
27,000
-1,000
-4% -$181K 0.18% 168
2015
Q1
$4.85M Sell
28,000
-3,000
-10% -$520K 0.15% 177
2014
Q4
$5.74M Buy
+31,000
New +$5.74M 0.15% 165